隐球菌荚膜体内生长机制研究进展

中国真菌学杂志　 2011, Vol. 6 　Issue (6): 377-380.

隐球菌荚膜体内生长机制研究进展

陈敏, 潘炜华, 廖万清

上海长征医院皮肤病与真菌病研究所上海市医学真菌分子生物学重点实验室全军真菌病重点实验室中国医学真菌保藏管理中心隐球菌专业实验室, 上海, 200003

收稿日期:2011-07-13 出版日期:2011-12-28 发布日期:2011-12-28
通讯作者: 廖万清,E-mail:liaowanqing@sohu.com;潘炜华,E-mail:panweihua@medmail.com.cn E-mail:liaowanqing@sohu.com;panweihua@medmail.com.cn
作者简介:陈敏,男(汉族),硕士,主治医师.E-mail:chenmin9611233@yahoo.com.cn
基金资助:
国家自然科学基金(80171335);上海市科委基金(10dz2220100)

Received:2011-07-13 Online:2011-12-28 Published:2011-12-28

摘要/Abstract

摘要： 隐球菌(Cryptococcus neoformans and Cryptococcus gattii)最常侵犯人类或哺乳动物的中枢神经系统,引起致命的隐球菌性脑膜脑炎(Cryptococcal meningitis),已是目前临床上最重要的致病真菌之一。

中图分类号:

R519

陈敏, 潘炜华, 廖万清. 隐球菌荚膜体内生长机制研究进展[J]. 中国真菌学杂志, 2011, 6(6): 377-380.

[1] Kronstad JW,Attarian R,Cadieux B.Expanding fungal pathogenesis:Cryptococcus breaks out of the opportunistic box[J]. Nat Rev Microbiol,2011,9(3):193-203.
[2] Dromer F,Mathoulin-Pelissier S,Launay O.Determinants of disease presentation and outcome during cryptococcosis:the CryptoA/D study[J]. PLoS Med,2007,4(2):e21.
[3] Lortholary O,Poizat G,Zeller V.Long-term outcome of AIDS associated cryptococcosis in the era of combination antiretroviral therapy[J]. AIDS,2006,20(17):2183-2191.
[4] Zaragoza O,Rodrigues ML,De Jesus M.The capsule of the fungal pathogen Cryptococcus neoformans[J]. Adv Appl Microbiol,2009,68:133-216.
[5] Ma H,May RC.Virulence in Cryptococcus species[J]. Adv Appl Microbio1,2009,67:131-190.
[6] Maxson ME,Cook E,Casadevall A.The volume and hydration of the Cryptococcus neoformans polysaccharide capsule[J]. Fungal Genet Biol,2007,44(3):180-186.
[7] Doering TL.How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans[J]. Annu Rev Microbiol,2009,63:223-247.
[8] Frases S,Nimrichter L,Viana NB.Cryptococcus neoformans capsular polysaccharide and exopolysancharide fractions manifest physical,chemical,and antigenic differences[J]. Eukaryot Cell,2008,7 (2):319-327.
[9] McFadden D,Zaragoza O,Casadevall A.The capsular dynamics of Cryptococcus neoformans[J]. Trends Microbiol,2006,14(11):497-505.
[10] McFadden DC,Fries BC,Wang F.Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans[J]. Eukaryot Cell,2007,6(8):1464-1473.
[11] McFadden DC,De Jesus M,Casadevall A.The physical properties of the capsular polysaccharides from Cryptococcus neoformans suggest features for capsule construction[J]. J Biol Chem,2006,28 1 (4):1868-1875.
[12] Murphy JW.Influence of cryptococcal antigens on cell-mediated immunity[J]. Rev Infect Dis,1988,10 (Suppl 2):S432-435.
[13] Ma H,Croudace JE,Lammas DA.Expulsion of live pathogenic yeast by macrophages[J]. Curr Biol,2006,16(21):2156-2160.
[14] Mansour MK,Levitz SM.Interactions of fungi with phagocytes[J]. Curr Opin Microbiol,2002,5(4):359-365.
[15] Shao X,Mednick A,Alvarez M.An innate immune system cell is a major determinant of species-related susceptibility differences to fungal pneumonia[J]. J Immunol,2005,175(5):3244-3251.
[16] Feldmesser M,Kress Y,Casadevall A.Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection[J]. Microbiology,2001,147 (8):2355-2365.
[17] Frases S,Pontes B,Nimrichter L.A Capsule of Cryptococcus neoformans grows by enlargement of polysaccharide molecules[J]. Proc Natl Acad Sci USA,2009,106 (4):1228-1233.
[18] Granger DL,Perfect JR,Durack DT.Virulence of Cryptococcus neoformans.Regulation of capsule synthesis by carbon dioxide[J]. J Clin Invest,1985,76(2):508-516.
[19] Vartivarian SE,Anaissie EJ,Cowart RE.Regulation of cryptococcal capsular polysaccharide by iron[J]. J Infect Dis,1993,167(1):186-190.
[20] Rivers J,Feldmesser M,Cammer M.Organ-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infection[J]. Infect Immun,1998,66(10):5027-5030.
[21] Zaragoza O,Casadevall A.Experimental modulation of capsule size in Cryptococcus neoformans[J]. Biol Proced Online,2004,6(1):10-15.
[22] Nimrichter L,Frases S,Cinelli LP.Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations[J]. Eukaryot Cell,2007,6 (8):1400-1410.
[23] Zaragoza O,Telzak A,Bryan RA.The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans enlarges by distal growth and is rearranged during budding[J]. Mol Microbiol,2006,59 (1):67-83.
[24] Griffith CL,Klutts JS,Zhang L.UDP-glucose dehydrogenase plays multiple roles in the biology of the pathogenic fungus Cryptococcus neoformans[J]. J Biol Chem,2004,279(49):51669-51676.
[25] Yoneda A,Doering TL.A eukaryotic capsular polysaacharide is synthesized intracellularly and secreted via exocytoeis[J]. Mol Biol Cell,2006,17(12):5131-5140.
[26] Gates MA,Thorkildson P,Kozel TR.Molecular architecture of the Cryptococcus neoformans capsule[J]. Mol Microbiol,2004,52(1):13-24.
[27] Zaragoza O,Fries BC,Casadevall A. Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO2[J]. Infect Immun,2003,71(11):6155-6164.
[28] Kozubowski L,Lee SC,Heitman J.Signalling pathways in the pathogenesis of Cryptococcus[J]. Cell Microbiol,2009,11(3):370-380.
[29] Loftus B J,Fung E,Roncaglia P.The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans[J]. Science,2005,307(5713):1321-1324.
[30] Chang YC,Kwon-Chung KJ.Isolation of the third capsule-associated gene,CAP 60,required for virulence in Cryptococcus neoformans[J]. Infect lmmun,1998,66(5):2230-2236.
[31] Chang YC,Kwon-Chung KJ.Isolation,characterization,and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans[J]. J Bacteriol 1999,181 (18):5636-5643.
[32] Chang YC,Kwon-Chung KJ.Complementation of a capsule-deficient mutation of Cryptocoocus neoformans restores its virulence[J]. Mol Cell Biol,1994,14(7):4912-4919.
[33] Chang YC,Penoyer LA,Kwon-Chung KJ.The second capsule gene of Cryptococcus neoformans,CAP 64,is essential for virulence[J]. Infect Immun,1996,64(6):1977-1983.
[34] Klutts JS,Doering TL.Cryptococcal xylosyltransferase 1 (Cxt1 p)from Cryptococcus neoformans plays a direct role in the synthesis of capsule polysaccharides[J]. J Biol Chem,2008,283(21):14327-14334.

隐球菌荚膜体内生长机制研究进展

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	朱信霖, 洪南, 张超, 潘炜华, 蔡良奇, 李小静, 陈敏, 廖万清. 11例肾移植术后合并隐球菌病患者的新生隐球菌菌株遗传多样性研究[J]. 中国真菌学杂志, 2020, 15(6): 338-343.
[2]	邢小微, 张家堂. 隐球菌性脑膜炎的诊断进展[J]. 中国真菌学杂志, 2020, 15(6): 378-380.
[3]	黄进宝, 兰长青, 翁恒, 林清华. 肋骨隐球菌感染2例报道并文献复习[J]. 中国真菌学杂志, 2020, 15(5): 278-282.
[4]	赵静宇, 刘意抒, 方伟, 廖万清, 王桂祯, 顾菊林. 新生隐球菌酵母双杂交cDNA文库的构建及鉴定[J]. 中国真菌学杂志, 2020, 15(3): 134-137.
[5]	陶鹏飞, 杨欣平, 李正伦, 周奇文, 闵海燕, 钱庆锦. 30例艾滋病合并侵袭性隐球菌病的临床特征及治疗转归[J]. 中国真菌学杂志, 2020, 15(3): 150-153.
[6]	马玉帛, 张逸, 黄晨, 王晓雯, 李若瑜. 自然杀伤细胞在真菌感染免疫的研究进展[J]. 中国真菌学杂志, 2020, 15(3): 175-178.
[7]	张涓, 李晓会, 冯学玲, 张晶晶. 苦豆子生物碱抗烟曲霉、须癣毛癣菌和新生隐球菌的作用研究[J]. 中国真菌学杂志, 2020, 15(2): 72-77.
[8]	王莉琳, 李爱新, 杨雪, 汪雯, 吴昊. 67例艾滋病合并新生隐球菌性脑膜脑炎临床分析[J]. 中国真菌学杂志, 2019, 14(6): 342-345.
[9]	何沅鸿, 谭清, 杨彤彤, 何盛华, 王印, 周锐峰, 蔡琳. 两性霉素B治疗124例AIDS合并隐球菌脑膜炎的有效性及安全性研究[J]. 中国真菌学杂志, 2019, 14(6): 346-350.
[10]	黄进宝, 李红艳, 兰长青, 吕骁, 林志来, 王新航, 张宏英, 邹盛华, 翁恒. 两种血清隐球菌荚膜多糖抗原检测方法在肺隐球菌病中的应用研究[J]. 中国真菌学杂志, 2019, 14(5): 264-269.
[11]	鲁雁秋, 吴玉珊, 邱丹, 陈耀凯. 重庆地区149例艾滋病合并新生隐球菌性脑膜脑炎病例的回顾性研究[J]. 中国真菌学杂志, 2019, 14(4): 204-209.
[12]	赖锐, 宋英, 刘惟优, 袁小亮. 隐球菌荚膜多糖GXM纯化方法的改良研究[J]. 中国真菌学杂志, 2019, 14(4): 228-231.
[13]	王向熙, 余进, 李若瑜, 万喆, 张晓梅, 王爱平. 非霍奇金淋巴瘤伴播散性隐球菌感染1例[J]. 中国真菌学杂志, 2019, 14(4): 232-234.
[14]	雷岩, 方伟, 张超, 廖万清. 体外棋盘法分析粗糠柴苦素与氟康唑联合抗隐球菌作用[J]. 中国真菌学杂志, 2019, 14(2): 90-94.
[15]	王光裕, 陈敏, 洪南, 王升启, 廖万清, 杨英. 采用分子生物学技术诊断隐球菌脑膜脑炎的研究[J]. 中国真菌学杂志, 2019, 14(2): 95-98.